Scientists zoom in on microbial messages at the molecular level to understand how the microbiome shapes health.

GC Therapeutics (GCTx), a Harvard startup, announced its launch to scale and its technology TFome™, the world’s first “plug and play” induced pluripotent stem cell (iPSC) programming platform for cell therapies in multiple therapeutic areas. 

Startup launches based on a Harvard discovery to address the global plastics crisis.

Procedure conducted by Harvard Medical School physician-scientists at Massachusetts General Hospital raises hopes about improving and saving lives amid human organ shortages and reducing health disparities associated with organ failure and transplantation.